← Back to all trials
Recruiting
NCT05719233
Assessment of Neuropsychiatric Function in Patients With Interstitial Lung Disease
Conditions: Lung Diseases, Interstitial
Sex: All
Ages: 18 Years – 70 Years
Healthy volunteers: 1
Enrollment: 60
Sponsor: Assiut University
Location: Egypt
Summary
Research on the impact of lung diseases on neuropsychological functioning has revealed impaired cognitive processing in patients with a variety of pulmonary disorders.
While the mechanisms responsible for the association of pulmonary diseases and neurocognitive functioning remain unclear, some researchers have attributed it to reduced oxygenation of the brain.
Early detection and accurate management of comorbidity have benefits in reducing ILD morbidity and mortality.
Eligibility Criteria
Inclusion Criteria:Interstitial lung disease patients diagnosed using high resolution computed tomography to confirm the diagnosisExclusion Criteria:Patients who refuse to participate in the study.Age less than 18,A history of neurological and/or developmental disorders and related drug treatment,A head injury with loss of consciousness,Active alcohol or drug abuse or a history of abuse prior to testing,A history of any psychiatric disorder or treatment, neurological disorders, psychological disorders, dementia, Alzheimer's disease, end-organ failure conditions
Source: ClinicalTrials.gov (NCT05719233). StuddyBuddy aggregates publicly available trial information.